Concepedia

Publication | Open Access

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects

37

Citations

26

References

2017

Year

References

YearCitations

Page 1